Xeriant, Inc.
XERI
$0.0151
$0.00085.59%
Weiss Ratings | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Very Weak | |||
Risk Index | Very Weak | |||
Risk Grade | E+ | |||
Reward Grade | E | |||
Rating Factors | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Very Weak | |||
Solvency Index | Very Weak | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.63 | |||
Price History | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -5.03% | |||
30-Day Total Return | -11.18% | |||
60-Day Total Return | -2.58% | |||
90-Day Total Return | 19.84% | |||
Year to Date Total Return | -13.22% | |||
1-Year Total Return | -9.58% | |||
2-Year Total Return | -49.50% | |||
3-Year Total Return | -87.29% | |||
5-Year Total Return | -35.19% | |||
52-Week High % Change | -62.16% | |||
52-Week Low % Change | 51.00% | |||
Price | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $0.04 | |||
52-Week Low Price | $0.01 | |||
52-Week Low Price (Date) | Nov 01, 2024 | |||
52-Week High Price (Date) | May 16, 2024 | |||
Valuation | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 9.94M | |||
Enterprise Value | 14.82M | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | 0.00 | |||
Earnings Per Share Growth | -35.71% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | -- | |||
Price/Book (Q) | -1.57 | |||
Enterprise Value/Revenue (TTM) | -- | |||
Price | $0.02 | |||
Enterprise Value/EBITDA (TTM) | -7.64 | |||
Enterprise Value/EBIT | -7.63 | |||
Market Cap Category | Nano Cap | |||
Dividends and Shares | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 596.20M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 561 491 9595 | |||
Address | Innovation Centre 1 Boca Raton, FL 33431 | |||
Website | www.xeriant.com | |||
Country | United States | |||
Year Founded | -- | |||
Profitability | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -- | |||
Profit Margin | -- | |||
Management Effectiveness | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -598.34% | |||
Return on Equity | -- | |||
Income Statement | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | -- | |||
Total Revenue (TTM) | -- | |||
Revenue Per Share | -- | |||
Gross Profit (TTM) | -- | |||
EBITDA (TTM) | -1.94M | |||
EBIT (TTM) | -1.94M | |||
Net Income (TTM) | -2.31M | |||
Net Income Avl. to Common (TTM) | -2.31M | |||
Total Revenue Growth (Q YOY) | -- | |||
Earnings Growth (Q YOY) | 65.42% | |||
EPS Diluted (TTM) | 0.00 | |||
EPS Diluted Growth (Q YOY) | 75.00% | |||
Balance Sheet | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 254.20K | |||
Cash Per Share (Q) | $0.00 | |||
Total Current Assets (Q) | 268.60K | |||
Total Preferred Equity (Q) | 0.00 | |||
Total Equity (Q) | -8.69M | |||
Current Ratio (Q) | 0.030 | |||
Book Value Per Share (Q) | -$0.01 | |||
Total Assets (Q) | 276.60K | |||
Total Current Liabilities (Q) | 8.97M | |||
Total Debt (Q) | 8.00M | |||
Total Liabilities (Q) | 8.97M | |||
Total Common Equity (Q) | -5.82M | |||
Cash Flow | XERI - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 0.00 | |||
Cash from Financing (TTM) | 1.75M | |||
Net Change in Cash (TTM) | 215.20K | |||
Levered Free Cash Flow (TTM) | -1.00M | |||
Cash from Operations (TTM) | -1.54M | |||